Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)
Apply
AB-1009
A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step